Liver enriched transcription factors and differentiation of hepatocellular carcinoma

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 1, 1999, Pages 19-24

  Hayashi, Y ^a   Wang, W ^a   Ninomiya, T ^b   Nagano, H ^a   Ohta, K ^b   Itoh, H ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

CCAAT enhancer binding protein; D binding protein; Hepatic nuclear factors; Liver enriched transcription factor

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; BINDING PROTEIN; DNA; MESSENGER RNA; NUCLEAR FACTOR I; NUCLEAR FACTOR III; NUCLEAR FACTOR IV; NUCLEAR FACTOR VI; NUCLEAR PROTEIN; PREALBUMIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; DNA SEQUENCE; ENHANCER REGION; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION;

EID: 0032949466     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.1.19     Document Type: Article

References (86)

1. 1 Maniatis S, Goodbourn S, Fischer J. Regulation of inducible and tissue-specific gene expression. Science 1987; 245:1237-45.
2. 2 Zaret KS. Genetic control of hepatocyte differentiation. In: Arias IM, Boyer JL, Fausto N, et al, eds. The liver: biology and pathology, 3rd ed. New York: Raven Press, 1994:53-68.
3. 3 Cereghini S. Liver-enriched transcription factors and hepatocyte differentaion. FASEB J 1996;10:267-82.
4. 4 Withdrawn.
5. 5 Mehta R. The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. Cancer Lett 1995;93:85-102.
6. 6 Lichtsteiner S, Wuarin J, Schibler U. The interplay of DNA binding proteins on the promoter of mouse albumin gene. Cell 1987;5:963-73.
7. 7 Cereghini S, Blumenfeld M, Yaniv M. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci USA 1988;85:7937-41.
8. 8 Hardon E, Paonessa G, Frain M, et al. Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J 1988;7:1711-19.
9. 9 Courtois G, Morgan JG, Campbell LA, et al. Interaction of a liver-specific nuclear factor with the fibrinogen and alpha-antitrypsin promoters. Science 1987;238:688-92.
10. 10 Costa RH, Lai E, Grayson DR, et al. The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor(s) at two other sites. Mol Cell Biol 1988;8:81-90.
11. 11 Eguchi H, Westin S, Ström A. Gene structure and expression of the rat cytochrome P450IIC13, polymorphic male-specific cytochrome in the P450IIC subfamily. Biochemistry 1991;30:10844-9.
12. 12 Xanthopoulos K, Prezioso V, Chen W, et al. The different tissue transcription patterns of genes for HNF-1, C EBP, HNF3, and HNF-4, protein factors that govern liver specific transcription. Proc Natl Acad Sci USA 1991;88: 3807-11.
13. 13 Frain M, Swart G, Monaci P. The liver-specific transcription factor LFB1 contains a highly diverged homeobox DNA binding domain. Cell 1989;59:145-57.
14. 14 DeSimone V, DeMagistris L, Lazzaro D, et al. LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J 1991;10:1435-43.
15. 15 Rey-Campos J, Chouard T, Yaniv M, et al. vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J 1991;10:1445-57.
16. 16 Mendel DB, Hansen LP, Graves MK, et al. HNF-1α and HNF-1β (vHNF-1) share dimerization and homeodomains, but not activation domains, and form heterodimers in vitro. Genes Dev 1991;5:1042-56.
17. 17 Cereghini S, Ott MO, Power S, et al. Expression pattern of vHNF-1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles. Development 1992;116:783-97.
18. 18 Tsutsumi K, Ito K, Ishikawa K. Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene. Mol Cell Biol 1989;9:4923-31.
19. 19 Chang HK, Wang BY, Yuh CH, et al. A liver-specific nuclear factor interacts with a region of the large surface protein gene in human hepatitits B virus. Mol Cell Biol 1989;9: 5189-97.
20. 20 Cereghini S, Blumenfeld M, Yaniv M. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev 1988;2:957-74.
21. 21 Cereghini S, Yaniv M, Cortese R. Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF-1/LFB1. EMBO J 1990;9:2257-63.
22. 22 Ninomiya T, Hayashi Y, Saijoh K, et al. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma. J Hepatol 1996;25:445-53.
23. 23 Kalkuhl A, Kaestner K. Buchmann A, et al. Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumors. Carcinogenesis 1996;17:609-12.
24. 24 Flodby P, Liao D.Z, Blanck A, et al. Expression of liver-enriched transcription factors C/EBPα C/EBPβ, HNF-1 and HNF-4 in preneoplastic nodules hepatocellular carcinoma in rat liver. Mol Carcinog 1996;17: 600-12.
25. 25 Wang W, Hayashi Y, Ninomiya T, et al. Expression of HNF-1α and HNF-1β in various histological differentiations of hepatocellular carcinoma. J Pathol 1998;184:272-8.
26. 26 Clairmont A, Ebert T, Weber H, et al. Lowered amounts of the tissue-specific tanscription factor LFB1 (HNF-1) correlate with decreased levels of glutathione S-transferase a messenger RNA in human renal cell carcinoma. Cancer Res 1994;54:1319-23.
27. 27 Sladek F, Zhong W, Lai E, et al. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990;10:1239-43.
28. 28 Costa R, Grayson D, Darnell J, Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α1-antirypsin gene. Mol Cell Biol 1989;9: 1415-25.
29. 29 Mietus-Snyder M, Sladek F, Ginsburg S, et al. Antagonism between apolipoprotein A1 regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein in liver and intestinal cells. Mol Cell Biol 1992;12:1708-18.
30. 30 Späth G, Weiss M. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentated hepatoma cells. Mol Cell Biol 1997;17:1913-22.
31. 31 Späth G, Weiss M. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 1998;140:935-46.
32. 32 Hoshizaki KD, Blackburn T, Price C, et al. Embryonic fat-cell lineage in Drosophila melanogaster. Development 1994;120:2489-99.
33. 33 Stumpf H, Senkel S, Rabes H, et al. The DNA binding activity of the liver transcription factors LFB1 (HNF1) and HNF4 varies coordinately in rat hepatocellular carcinoma. Carcinogenesis 1995;16:143-5.
34. 34 Ktistaki E, Talianidis I. Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science 1997;277:109-12.
35. 35 Ktistaki E, Ktistakis N, Papadogeorgaki E, et al. Recruitment of hepatocytre nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci USA 1995;92:9876-80.
36. 36 Viollet B, Kahn A, Raymondjean. Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol 1997; 17:4208-19.
37. 37 Johnson P. Identification of C/EBP basic region residues involved in DNA sequence recognition and half-site spacing preference. Mol Cell Biol 1993;13:6919-30.
38. 38 Landschulz W, Johnson P, McKnight S. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 1988;240:1759-64.
39. 39 Ellenberger T, Brandle C, Struhl K, et al. The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted a helices: crystal structure of the protein DNA complex. Cell 1993;71:1223-37.
40. 40 Cao Z, Umek R, McKnight S. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991;5:1538-52.
41. 41 Birkenmeier E, Gwynn B, Howard S, et al. Tissue-specific expression, developmental regulation, genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 1989;3:1146-56.
42. 42 Johnson P, Landschulz W, Graves B, et al. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1987;1:133-46.
43. 43 Landschulz W, Johnson P, Adashi E, et al. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 1988;2:786-800.
44. 44 Umek R, Friedman A, McKnight S. CCAAT-enhancer binding protein: a component of differentiation switch. Science 1991;251:288-92.
45. 45 Lin F, Lane M. CCAAT-enhancer binding protein a is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994;91:8757-61.
46. 46 Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994;8:1654-63.
47. 47 Samuelsson L, Stromberg K, Vikman K, et al. The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development. EMBO J 1991;10:3787-93.
48. 48 Lin FT, Lane MD. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 1992;6:533-44.
49. 49 Friedman AD, Landschulz WH, McKnight SL. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cell. Genes Dev 1989;3:1314-22.
50. 50 Herbst RS, Friedman N, Darnell JE, et al. Positive and negative regulatory elements in mouse albumin enhancer. Proc Natl Acad Sci USA 1989;86:1533-57.
51. 51 Costa RH, Grayson DR, Darnell JE. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha1-antitrypsin genes. Mol Cell Biol 1989;9:1415-25.
52. 52 Mischoulon D, Rana B, Nancy L, et al. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol Cell Biol 1992;12: 2553-60.
53. 53 Timchenko NA, Wilde M, Nakanishi M, et al. ACCAAT/enhancer-binding protein (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 1996;10:804-15.
54. 54 Withdrawn.
55. 55 Watkins, PJ, Condreay JP, Huber BE, et al. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res 1996;56:1063-7.
56. 56 Withdrawn.
57. 57 Akira S, Isshiki H, Sugita T, et al. A nuclear facter for IL-6 expression (NF-IL6) is a member of the C/EBP family. EMBO J 1990;9:1897-906.
58. 58 Tanaka T, Akira S, Yoshida K, et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacterial killing and tumor cytotoxicity by macrophages. Cell 1995;80:353-61.
59. 59 Screpanti I, Romani L, Musiani P, et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBPb-deficient mice. EMBO J 1995;14:1932-41.
60. 60 Natsuka S, Akira S, Nishio Y, et al. Macrophage differentiation specific expression of NF-IL6, a transcription factor for IL-6. Blood 1992;79:460-6.
61. 61 Zhang DE, Zhang P Wang ND, et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein a-deficient mice. Proc Natl Acad Sci USA 1997;94:569-74.
62. 62 Mueller C R, Maire P, Schibler U. DBP, a liver-enriched transcriptional activator is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell 1990;61:279-91.
63. 63 Lavery DJ, Schiblez V, Circadian transcription of the cholesterol-7α hydroxylase gene may involve the liver enriched b-ZIP-protein DBP. Genes Dev 1993;7:1871-84.
64. 64 Vinson CR, Hai T, Boyd S. Dimerization specificity of the leucine zipper-containing bZip motif on DNA-binding: prediction and rational design. Genes Dev 1993;7:2081-6.
65. 65 Falvey E, Marcacci L, Schibler U. DNA-binding specificity of PAR and C/EBP leucine zipper proteins: a single amino acid substitution in the C/EBP DNA-binding domain confers PAR-like specificity to C/EBP. Biol Chem 1996;377: 797-809.
66. 66 Lai E, Prezioso VR, Smith E, et al. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 1990;4:1427-36.
67. 67 Lai E, Prezioso VR, Tao W, et al. Hepatocyte nuclear factor 3α belongs to a gene family in mammals that is homelogous to the Drosophila homeotic gene fork head. Genes Dev 1991;5:416-27.
68. 68 Pani L, Overdier DG, Porcella A, et al. Hepatocyte nuclear factor 3β contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol Cell Biol 1992;12:3723-32.
69. 69 Weinstein DC, Altaba AR, Chen WS, et al. The winged-helix transcription factor HNF-3β is required for notochord development in the mouse embryo. Cell 1994;78:575-88.
70. 70 Ang SL, Weirds A, Wong D, et al. The formation and maintenance of the definitive endoderm lineage in mouse: involvement of HNF-3/forkhead proteins Development 1993;119:1301-15.
71. 71 Monaghan AP, Kaestner KH, Grau E, et al. Postimplantation expression pattern indicates a role for the mouse forkhead/HNF-3α, β, γ genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm. Development 1993;119:567-78.
72. 72 Jackson DA, Rowader KE, Stevens K, et al. Modulation of liver-specific transcriptions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol Cell Biol 1993;13:2401-10.
73. 73 Kuo CJ, Conley PB, Chen L, et al. A transcriptional hierarchy involved in mammalian cell type specification. Nature 1992;355:457-61.
74. 74 DiPersio CM, Jackson DA, Zaret KS. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol Cell Biol 1991;11:4405-14.
75. 75 Caron JM. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol Cell Biol 1990; 10:1239-43.
76. 76 Eisenmann DM, Kim SK. Signal transduction and cell fate specification during Caenorhabditis elegans vulval development. Curr Opin Genet Dev 1994;4:508-16
77. 77 Pani L, Clevidence DE, Qian X, et al. The restricted promoter activity of the liver transcription factor hepatocyte nuclear factor-3β involves a cell-specific factor and positive autoactivation. Mol Cell Biol 1992;12:552-62.
78. 78 Peterson RS, Clevidence DE, Ye H, et al. Hepatocyte nuclear factor-3α promoter regulation involves recognition by cell-specific factors, thyroid transcription factor-1, and autoactivation. Cell Growth Differ 1997;8:69-82.
79. 79 Mizuguchi T, Mitaka T, Hirata K, et al. Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes. J Cell Physiol 1998;174:273-84.
80. 80 Lemaigre FP, Durviaux SM, Truong O, et al. Hepatocyte nuclear factor 6, a transcription factor that contains a novel type of homeodomain and a single cut domain. Proc Natl Acad Sci USA 1996;93:9460-4.
81. 81 Samadani U, Costa RH. The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression. Mol Cell Biol 1996;16:6273-84.
82. 82 Landry C, Clotman F, Hioki T, et al. HNF-6 is expressed in endoderm derivatives and nervous system of the mouse embryo and participates in the cross-regulatory network of liver-enriched transcription factors. Dev Biol 1997;192: 247-57.
83. 83 Rausa F, Samadani U, Ye H, et al. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its gene HNF-3β in the developing murine liver and pancreas. Dev Biol 1997;192;228-46.
84. 84 Rim KS, Sakamoto M, Watanabe H, et al. Pathology and DNA cytophometry of small hepatocellular carcinoma with a nodule in nodule appearance - evidence for stepwise progression of hepatocellular carcinoma. Jpn J Clin Oncol 1992;23:26-33.
85. 85 Nakashima O, Sugihara S, Kage M, et al. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins, Hepatology 1995;22:101-5.
86. 86 Nakano M, Saito A, Yamamoto M, et al. Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997;17:41-6.